Organisation paid for research Program year 2021 Source: CMS Open Payments

Harbin Clinic

Neither a doctor nor a teaching hospital

Research payments

$42,550

14 payments

Through program year 2021, Harbin Clinic is reported as receiving $42,550 in research payments, across 14 payments.

By program year

3 rows
Year Kind Amount Payments
2021 Research $5,180 1
2020 Research $14,142 7
2019 Research $23,228 6

Breakdown

Who paid Research payments · program years 2019–2021
  1. Abbott Laboratories $26,800 7 payments
  2. E.R. Squibb & Sons, L.L.C. $15,750 7 payments
Studies the money was for Research payments · program years 2019–2021
  1. Optim Lead Insulation Material (OPTIMUM) Registry $20,800 4 payments
  2. Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices $12,405 4 payments
  3. Optim Lead Insulation Material (OPTIMUM) Registry $6,000 3 payments
  4. Lung cancer molecular profiling and clinical outcomes in US oncology community practices $2,845 2 payments
  5. A US Multi-Site Observational Study in Patients With Unresectable And Metastatic Melanoma: The OPTIMIzE Study $500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record